In Practice: managing practice billing The college has developed new resources to help members in better managing their practice’s billing.
COVID-19 Vaccine Claims Scheme now open GPs will play a leading role by providing a medical report for potential claimants under the scheme.
COVID vaccination for children aged 5–11 to begin in January Pfizer’s paediatric vaccine has received its final approval, with ATAGI’s clinical guidance recommending a dosage interval of eight weeks.
Decision aid launched for those with COVID-19 vaccine concerns Prominent public health experts have collaborated to develop an online tool backed by the National Centre for Immunisation Research and Surveillance.
Travel medicine in a new era One expert examines what questions GPs can expect and the best advice to give.
First Omicron studies hint at enhanced role for boosters The first laboratory studies have emerged on Omicron and its impact on vaccination, suggesting ‘extensive but incomplete’ loss of protection – but the picture for severe disease remains unclear.
Charges dropped against practice nurse in vaccine fraud case The case, which involved a nurse being accused of falsely administering a COVID-19 vaccine, raised alarm across the medical community.
Vaccine myocarditis risk reaches 1 in 10,000 for adolescent boys But while the rate of Pfizer-related myocarditis continues to increase in males aged 12–17, research cited by the TGA indicates the risk is still dwarfed by the threat COVID-19 poses to this cohort.
COVID-19 vaccines and children: What GPs need to know The TGA has paved the way for COVID-19 vaccination in children aged 5–11 from early next year. What part will general practice play?
Five-month booster possible ‘in certain circumstances’: ATAGI No changes have been prompted by the Omicron variant, but the advisory group says a shortened minimum gap can be followed if specific conditions are met.